nedaplatin has been researched along with Adenocarcinoma in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.50) | 18.7374 |
| 1990's | 7 (17.50) | 18.2507 |
| 2000's | 13 (32.50) | 29.6817 |
| 2010's | 19 (47.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, SH; Fan, T; Quan, CY; Shao, XH; Song, YJ; Zhang, Y | 1 |
| Hayakawa, K; Inoue, Y; Matsuo, K; Niibe, Y; Onda, T | 1 |
| Abou Taleb, H; Baba, T; Hamanishi, J; Kido, A; Konishi, I; Matsumura, N; Togashi, K; Yamaguchi, K; Yamanoi, K; Yoshioka, Y | 1 |
| Cai, L; Li, CH; Li, DD; Liu, MY; Liu, W | 1 |
| Shi, L; Tang, Y; Teng, XZ; Wang, W | 1 |
| Kigawa, G; Matsubara, T; Matsumiya, A; Mizukami, H; Nemoto, H; Saito, M; Tanaka, J; Tate, G; Umemoto, T | 1 |
| Qiu, ZQ; Zhao, K | 1 |
| Fukuchi, M; Ieta, K; Inose, T; Kato, H; Kuwano, H; Miyazaki, T; Nakajima, M; Ojima, H; Saito, K; Sakai, M; Sano, A; Sohda, M; Suzuki, S; Tanaka, N; Yokobori, T | 1 |
| Chen, KN; Chen, Y; Fan, MY; Li, XT; Liang, Z; Sun, Y; Sun, YS; Wang, ZL; Wu, Y; Xiong, HC; Yan, WP; Zhang, XY | 1 |
| Guo, J; Han, J; Ji, Y; Pan, P; Yu, C; Zhou, X; Zhu, W | 1 |
| Hu, T; Liu, H; Shi, Y; Song, SQ; Zhang, GN | 1 |
| Hayakawa, K; Imai, M; Jobo, T; Matsunaga, K; Matsuo, K; Niibe, Y; Tsunoda, S; Unno, N | 1 |
| Gong, Y; Hou, M; Huang, M; Lu, Y; Ren, L; Wang, J; Wei, Y; Zhou, L; Zhou, X; Zhu, J | 1 |
| Chen, XB; Fan, QX; Geng, L; Han, JW; Jiao, ZM; Lu, P; Lu, SP; Lu, TY; Luo, SX; Ma, ZY; Song, M; Wang, GJ; Wang, JS; Wang, R; Wang, RL; Wu, XA; Zhang, MZ; Zhao, YF | 1 |
| Furuta, T; Futami, H; Hamaya, Y; Ikuma, M; Iwaizumi, M; Kodaira, C; Muramatsu, A; Nishino, M; Osawa, S; Sugimoto, K; Takagaki, K; Yamada, T; Yoshida, K | 1 |
| Cao, W; Geng, M; Jiang, J; Jin, Y; Li, H; Lou, G; Xi, W; Xu, C; Zhao, S | 1 |
| Guo, JF; Nie, XY; Peng, J; Wang, B; Wu, F; Xing, H; Zhang, B; Zhu, GY | 1 |
| Honda, T; Kondo, T; Murakami, S; Noda, K; Oshita, F; Saito, H; Yamada, K | 1 |
| Akutsu, Y; Kono, T; Matsubara, H; Natsume, T; Ohira, G; Ota, T; Saito, H; Shuto, K; Toma, T; Uesato, M | 1 |
| Chen, X; Li, H; Li, K; Li, X; Liu, Y; Lou, G; Yin, M; Zhang, H | 1 |
| Ke, QH; Liu, Z; Su, XY; Yang, JY; Zhang, WT; Zhou, SQ | 1 |
| Cai, L; Guo, K; Hao, CL; Li, Z; Lin, P; Rong, TH; Wang, WP; Zhang, LJ; Zhang, Y; Zhu, JF | 1 |
| Arakawa, A; Furukawa, N; Hirashima, Y; Itani, Y; Ito, K; Murakoshi, H; Tabata, T; Takekuma, M; Takeuchi, S; Tsubamoto, H | 1 |
| Isohashi, F; Kamiura, S; Kimura, T; Mabuchi, S; Ogawa, K; Ohta, Y; Okazawa, M; Sasano, T; Suzuki, O; Yoshioka, Y | 1 |
| Furukawa, M; Kawano, T; Komatsu, M; Kubota, A | 1 |
| Kinoshita, K; Tanaka, M; Yoshida, M | 1 |
| Ariyama, H; Baba, E; Harada, M; Kusaba, H; Mitsugi, K; Nakano, S; Qin, B; Shibata, Y; Takii, Y; Tanaka, R | 1 |
| Igaki, H; Nakagawa, K; Nakamura, N; Ohtomo, K; Sasano, N; Shiraishi, K; Tago, M; Yamashita, H | 1 |
| Arai, M; Arai, T; Hamada, Y; Hayakawa, K; Imai, M; Jobo, T; Kanai, T; Kawaguchi, M; Niibe, Y; Tsunoda, S; Unno, N; Yago, K | 1 |
| Imawari, M; Kaneko, K; Kiuchi, Y; Kogo, M; Suzuki, A; Yoneyama, K | 1 |
| Chung, YS; Kato, Y; Kubo, T; Maeda, K; Nakata, B; Nitta, A; Okuno, M; Sowa, M; Yashiro, M | 1 |
| Hashimoto, N; Kamiura, S; Kobayashi, K; Ohira, H; Saji, F; Samejima, Y; Sawai, K; Seino, H | 1 |
| Adachi, S; Hori, Y; Koyama, K; Ogasawara, T; Oku, H; Takemura, T; Tsubamoto, H; Tsuji, Y | 1 |
| Asamoto, H; Fukuoka, M; Furuse, K; Kimura, I; Niitani, H; Sakuma, A; Yamaguchi, Y | 1 |
| Akamatsu, Y; Hirabayashi, K; Nakanishi, Y; Nakazuma, Y; Ohta, M; Okada, E; Sezaki, H | 1 |
| Hayasaki, K; Horiuchi, M; Inuyama, Y; Komiyama, S; Miyake, H; Ota, K | 2 |
| Hata, T; Ikeda, M; Kuramoto, H; Nishimura, H; Noda, K; Sasaki, H; Takahashi, T; Tanaka, K; Terashima, Y; Yakushiji, M | 1 |
| Eguchi, K; Fukuda, M; Hara, K; Kojima, A; Ohe, Y; Oshita, F; Saijo, N; Sasaki, Y; Shinkai, T; Tamura, T | 1 |
| Eguchi, K; Noguchi, M; Ohta, T; Saijo, N; Sasaki, Y; Shinkai, T; Tamura, T | 1 |
2 review(s) available for nedaplatin and Adenocarcinoma
| Article | Year |
|---|---|
Comparison of nedaplatin and irinotecan for patients with squamous and nonsquamous cell carcinoma of the lung: meta-analysis of four trials.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Pilot Projects; Risk Factors; Survival Rate; Treatment Outcome | 2011 |
[A case of long-term survival after resection for postoperative solitary adrenal metastasis from esophageal adenocarcinoma].
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Adrenalectomy; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Esophageal Neoplasms; Esophagectomy; Fluorodeoxyglucose F18; Fluorouracil; Humans; Lymph Node Excision; Male; Organoplatinum Compounds; Positron-Emission Tomography | 2010 |
20 trial(s) available for nedaplatin and Adenocarcinoma
| Article | Year |
|---|---|
Phase II Study of Concurrent Chemoradiotheapy Using Nedaplatin for Locally Advanced Uterine Cervical Carcinoma (KGROG0501): Final Results.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Treatment Outcome; Uterine Cervical Neoplasms | 2017 |
Randomized control study of nedaplatin or cisplatin concomitant with other chemotherapy in the treatment of advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Case-Control Studies; Cisplatin; Deoxycytidine; Docetaxel; Female; Follow-Up Studies; Gemcitabine; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Pemetrexed; Prognosis; Retrospective Studies; Survival Rate; Taxoids; Vinblastine; Vinorelbine; Young Adult | 2014 |
Efficacy of S-1 plus nedaplatin compared to standard second-line chemotherapy in EGFR-negative lung adenocarcinoma after failure of first-line chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Drug Combinations; Drug Therapy; ErbB Receptors; Female; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Mutation; Nausea; Neoplasm Staging; Organoplatinum Compounds; Oxonic Acid; Tegafur; Treatment Failure; Treatment Outcome; Vomiting | 2014 |
Expression of ERCC1, RRM1 and LRP in non-small cell lung cancers and their influence on chemotherapeutic efficacy of gemcitabine concomitant with nedaplatin.
Topics: Acute Kidney Injury; Adenocarcinoma; Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; DNA-Binding Proteins; Drug Resistance, Neoplasm; Endonucleases; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Nausea; Organoplatinum Compounds; Ribonucleoside Diphosphate Reductase; Thrombocytopenia; Treatment Outcome; Tumor Suppressor Proteins; Vault Ribonucleoprotein Particles; Vomiting | 2014 |
Phase II Study of Docetaxel, Nedaplatin, and 5-Fluorouracil Combined Chemotherapy for Advanced Esophageal Cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Prospective Studies; Survival Rate; Taxoids; Treatment Outcome | 2015 |
A comparative study of intensity-modulated radiotherapy and standard radiation field with concurrent chemotherapy for local advanced cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Enteritis; Female; Humans; Middle Aged; Organoplatinum Compounds; Radiation Injuries; Radiotherapy, Intensity-Modulated; Uterine Cervical Neoplasms; Young Adult | 2015 |
Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma (LAUCC): Kitasato Gynecologic Radiation Oncology Group (KGROG 0501)--initial analysis.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Female; Humans; Japan; Middle Aged; Organoplatinum Compounds; Radiotherapy, High-Energy; Uterine Cervical Neoplasms | 2008 |
Phase II evaluation of nedaplatin and paclitaxel in patients with metastatic esophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Prognosis; Survival Rate; Treatment Outcome | 2009 |
A phase II study of paclitaxel and nedaplatin as first-line chemotherapy in patients with advanced esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Esophageal Neoplasms; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Organoplatinum Compounds; Paclitaxel; Prognosis; Survival Rate; Treatment Outcome | 2009 |
A phase II trial of docetaxel plus nedaplatin and 5-fluorouracil in treating advanced esophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Remission Induction; Survival Rate; Taxoids; Thrombocytopenia | 2010 |
[Analysis of the initial efficacy of nedaplatin combined with megestrol in concurrent chemoradiotherapy for advanced cervical cancer].
Topics: Adenocarcinoma; Adult; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemoradiotherapy; Diarrhea; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Leukopenia; Megestrol; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Particle Accelerators; Radiotherapy, High-Energy; Remission Induction; Survival Rate; Thrombocytopenia; Uterine Cervical Neoplasms | 2011 |
Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: a Kansai Clinical Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Paclitaxel; Uterine Cervical Neoplasms | 2012 |
Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma: Kitasato Gynecologic Radiation Oncology Group (KGROG 0501).
Topics: Adenocarcinoma; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Combined Modality Therapy; Dose Fractionation, Radiation; Female; Humans; Organoplatinum Compounds; Radiotherapy, High-Energy; Uterine Cervical Neoplasms | 2007 |
[Concurrent chemoradiation therapy with nedaplatin for high-risk cervical cancer--clinical investigation of adverse events].
Topics: Adenocarcinoma; Adult; Aged; Anorexia; Antineoplastic Agents; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Diarrhea; Drug Administration Schedule; Female; Humans; Hysterectomy; Infusions, Intravenous; Middle Aged; Nausea; Neoadjuvant Therapy; Organoplatinum Compounds; Radiotherapy, Adjuvant; Uterine Cervical Neoplasms; Vomiting, Anticipatory | 2001 |
Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Balloon Occlusion; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Female; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Middle Aged; Organoplatinum Compounds; Survival Rate; Uterine Cervical Neoplasms; Uterine Neoplasms | 2001 |
[A randomized comparative study of 254-S plus vindesine (VDS) vs. cisplatin (CDDP) plus VDS in patients with advanced non-small cell lung cancer (NSCLC)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Survival Rate; Vindesine | 1992 |
[A late phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Organoplatinum Compounds | 1992 |
[An early phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers].
Topics: Adenocarcinoma; Anorexia; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Evaluation; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Organoplatinum Compounds; Thrombocytopenia | 1992 |
Phase II study of (glycolate-O,O') diammineplatinum(II), a novel platinum complex, in the treatment of non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Remission Induction; Time Factors | 1990 |
A case report of pulmonary adenocarcinoma responding to (glycolato-0,0') diammineplatinum (II), a new platinum complex.
Topics: Adenocarcinoma; Antineoplastic Agents; Clinical Trials as Topic; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Organoplatinum Compounds | 1987 |
18 other study(ies) available for nedaplatin and Adenocarcinoma
| Article | Year |
|---|---|
Nedaplatin-Induced Arrhythmia: Retrospective Analysis of Three Cases.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Arrhythmias, Cardiac; Atrial Premature Complexes; Carcinoma, Endometrioid; Cardiotoxicity; Dexamethasone; Heart Rate; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Small Cell Lung Carcinoma; Tachycardia, Sinus | 2017 |
A novel diagnostic criterion for lymph node metastasis in cervical cancer using multi-detector computed tomography.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Squamous Cell; Female; Humans; Hysterectomy; Irinotecan; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Multidetector Computed Tomography; Neoadjuvant Therapy; Organoplatinum Compounds; Precision Medicine; Uterine Cervical Neoplasms | 2013 |
[A case of esophageal squamous cell carcinoma with an adenocarcinoma component that dedifferentiated after chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Differentiation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorouracil; Humans; Liver Neoplasms; Male; Organoplatinum Compounds; Recurrence | 2014 |
CT Signs Can Predict Treatment Response and Long-Term Survival: A Study in Locally Advanced Esophageal Cancer with Preoperative Chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Preoperative Care; Prognosis; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2015 |
Addition of bevacizumab to neoadjuvant chemotherapy for Stage IV ovarian serous adenocarcinoma with multiple lymph node metastases: a case report.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Chemoradiotherapy, Adjuvant; Female; Humans; Lymph Nodes; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Cystic, Mucinous, and Serous; Organoplatinum Compounds; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Treatment Outcome | 2015 |
[Nedaplatin combined with tegafur in the treatment for advanced esophageal cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Remission Induction; Survival Rate; Tegafur; Vomiting | 2008 |
[A case of elderly esophageal adenocarcinoma successfully treated with daily low-dose nedaplatin (CDGP) and continuous infusion of 5-FU combined with radiation].
Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Endoscopy, Gastrointestinal; Esophageal Neoplasms; Fluorouracil; Humans; Infusions, Intravenous; Male; Organoplatinum Compounds; Radiography | 2009 |
The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hysterectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome; Uterine Cervical Neoplasms | 2012 |
The predictive value of histological tumor regression grading (TRG) for therapeutic evaluation in locally advanced esophageal carcinoma treated with neoadjuvant chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Docetaxel; Esophageal Neoplasms; Esophagectomy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Organoplatinum Compounds; Predictive Value of Tests; Proportional Hazards Models; Retrospective Studies; Survival Rate; Taxoids | 2012 |
Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemoradiotherapy; Chemoradiotherapy, Adjuvant; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hysterectomy; Lymph Node Excision; Medical Records; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Pelvic Neoplasms; Prognosis; Retrospective Studies; Survival Rate; Time Factors; Uterine Cervical Neoplasms; Young Adult | 2013 |
[Nedaplatin for recurrent cancer of the head and neck].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Organoplatinum Compounds; Survival Rate; Tegafur; Uracil | 2004 |
[Chemotherapy using nedaplatin for advanced gynecologic cancers].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Adenosquamous; Combined Modality Therapy; Female; Humans; Irinotecan; Middle Aged; Organoplatinum Compounds; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2004 |
In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell lines.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Drug Combinations; Drug Interactions; Humans; Organoplatinum Compounds; Paclitaxel; Stomach Neoplasms | 2005 |
Radiation therapy combined with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for Japanese stage II-IV esophageal cancer compared with cisplatin plus 5-fluorouracil regimen: a retrospective study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Cisplatin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome | 2006 |
Scoring system for predicting response to chemoradiotherapy, including 5-Fluorouracil and platinum, for patients with esophageal cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorouracil; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Organoplatinum Compounds; Outcome Assessment, Health Care; Predictive Value of Tests; Retrospective Studies | 2008 |
[Experimental study on the anti-tumor effect of CDDP derivatives against the gastric cancer cell lines].
Topics: Adenocarcinoma; Antineoplastic Agents; Carboplatin; Cell Division; Cisplatin; Humans; Organoplatinum Compounds; Stomach Neoplasms; Tumor Cells, Cultured | 1994 |
[Combination chemotherapy with 254-S, ifosfamide and peplomycin for advanced or recurrent cervical cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Peplomycin; Prognosis; Uterine Cervical Neoplasms | 1992 |
[A phase II clinical study of cis-diammine glycolato platinum, 254-S, for cervical cancer of the uterus].
Topics: Adenocarcinoma; Adult; Aged; Anorexia; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Middle Aged; Nausea; Organoplatinum Compounds; Uterine Cervical Neoplasms | 1992 |